DSIP peptide injection dosage ranges from about 100 mcg to 500 mcg in published research. Learn typical protocols, timing, safety, and legal status.
There is no FDA-approved DSIP peptide injection dosage, because delta sleep-inducing peptide has never been authorized as a drug in the United States. In published research and supplier documentation, the most commonly cited range is roughly 100 mcg to 500 mcg per injection, usually given in the evening. Those numbers are research reference points, not clinical recommendations, and anyone considering DSIP should speak with a licensed healthcare professional first.
What Is DSIP?
DSIP stands for delta sleep-inducing peptide, a nine-amino-acid peptide first isolated from rabbit brain tissue in the 1970s. Researchers identified it while investigating what appeared to be a sleep-promoting factor in cerebrospinal fluid.
In the decades since, DSIP has been studied for insomnia, opioid withdrawal, and stress responses. Most of those trials were small, short, and conducted under older regulatory standards, which is why the evidence base remains thin.
DSIP is not a hormone replacement therapy and it is not the same as a prescription sleep medication. It is a research compound widely sold online with a label stating it is for laboratory research use only.
DSIP Peptide Injection Dosage Ranges Reported in Research
Dosing in the DSIP literature is not standardized. Studies from the 1980s used intravenous and subcutaneous injections in amounts ranging from roughly 25 mcg to 1 mg, and later reviews noted that no consensus dose was ever established.
Most modern supplier references and community reports cluster around a narrower window:
| Route | Commonly cited amount | Typical frequency | Notes |
|---|---|---|---|
| Subcutaneous | 100–300 mcg | 3–5 evenings per week | Most frequently referenced range |
| Subcutaneous | 250–500 mcg | 3–5 evenings per week | Upper end of the cited range |
| Intravenous | 25–500 mcg | Clinical research settings only | Requires trained medical supervision |
| Intranasal | 100–500 mcg | Varies | Absorption is inconsistent |
A vial of dsip 5 peptide contains 5 mg of lyophilized powder, which is the format most researchers encounter. That single number drives every calculation that follows, so the concentration matters as much as the dose itself.
Building a DSIP Dosage Protocol: Timing and Frequency
A typical dsip dosage protocol separates two decisions: how much goes into each injection, and how often injections happen. Neither answer is settled science.
- Amount per injection: commonly cited at 100 mcg to 500 mcg.
- Frequency: three to five evenings per week is the most common pattern reported.
- Timing: 30 to 60 minutes before bed, since the reported effect is on sleep onset.
- Cycle length: anecdotal reports describe two- to four-week blocks followed by a break, though no trial has validated that schedule.
Reconstitution math
DSIP usually ships as a lyophilized powder that must be reconstituted with bacteriostatic water. The concentration you create determines how many units appear on an insulin syringe.
- 5 mg vial + 2 mL water = 2,500 mcg/mL, so 100 mcg is 4 units on a U-100 syringe.
- 5 mg vial + 1 mL water = 5,000 mcg/mL, so 100 mcg is 2 units.
- 5 mg vial + 5 mL water = 1,000 mcg/mL, so 100 mcg is 10 units.
Checking the math matters more than picking a specific number. A miscalculated concentration is one of the most frequently reported sources of unintended over-dosing in home peptide handling.
How DSIP Compares With Other Research Peptides
Unlike hgh peptide dosage charts, which are typically weight-based and adjusted against lab work, DSIP dosing in the literature is a flat microgram amount given to nearly everyone.
Compounds like pt 141 peptide spray dosage follow a third pattern: a fixed milligram dose delivered through a non-injection route. Delivery format changes the number entirely, so ranges are never directly comparable across different peptides.
Researchers studying sleep and circadian biology sometimes compare DSIP with epitalon dosage injection schedules, although those two compounds are studied for different endpoints and different mechanisms.
| Peptide | Common research format | How the amount is usually set |
|---|---|---|
| DSIP | Subcutaneous injection | Flat microgram dose, 100–500 mcg |
| Epitalon | Subcutaneous injection | Fixed milligram dose in short courses |
| PT-141 | Injection or nasal spray | Fixed dose that changes with the route |
| HGH | Subcutaneous injection | Weight-based and adjusted with lab results |
Safety, Side Effects, and Legal Status
DSIP is not FDA-approved for human use in the United States. Products sold online carry a research-only label, and they are not reviewed by the FDA for purity, sterility, or accurate labeling.
Reported side effects in older studies were generally mild and included drowsiness, headache, nausea, and injection-site irritation. Because those trials were small and short, long-term safety data simply does not exist.
Anyone using injectable peptides should work with a licensed clinician who can review interactions, monitor for adverse effects, and confirm the product's source.
Other practical cautions worth repeating:
- Never share needles or syringes, and dispose of sharps properly.
- Store reconstituted peptide refrigerated and protected from light.
- Seek medical care for signs of infection, allergic reaction, or severe drowsiness.
- Do not combine DSIP with sedatives, alcohol, or sleep medications without medical guidance.
Bottom Line
Most DSIP injection references land between 100 mcg and 500 mcg, given in the evening, three to five times per week. There is no universally accepted DSIP peptide injection dosage, and no regulatory body has reviewed the compound for human use.
If sleep is the underlying concern, proven options exist: cognitive behavioral therapy for insomnia, sleep hygiene changes, and FDA-approved medications prescribed by a clinician. Those routes come with known risk profiles and monitored oversight, which research peptides do not.
Frequently Asked Questions
What is a typical DSIP peptide injection dosage?
Most research and supplier references cite 100 mcg to 500 mcg per subcutaneous injection, taken in the evening. Frequency is usually described as three to five nights per week. There is no FDA-approved DSIP dose, and no consensus dose was ever established in clinical trials.
How long before bed should DSIP be injected?
Anecdotal protocols usually place the injection 30 to 60 minutes before sleep, since DSIP's reported effects are tied to sleep onset. Some people report next-morning grogginess when the amount is higher or the timing is later. It is wise to avoid driving until you know how you respond.
Is DSIP legal to buy in the United States?
DSIP is not approved by the FDA for human use, so it is sold as a research chemical rather than a medication. That labeling means the product is not reviewed for purity, sterility, or accurate dosing. Personal importation and possession sit in a legal gray area, and state laws vary.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.